Nedocromil is recommended for the treatment of bronchial asthma where regular preventative anti-inflammatory therapy is indicated and, in particular, in patients whose asthma is not adequately controlled by bronchodilators alone. Nedocromil may be given in addition to all existing therapies and in many cases will provide added therapeutic benefit.
For this indication, competent medicine agencies globally authorize below treatments:
8 - 16 mg
From 4 To 8 mg 2 time(s) per day every day
The initial dose is 4 mg four times daily. Once control of symptoms has been achieved it may be possible to reduce the dose to a maintenance dose of 4mg twice daily.
Nedocromil is intended for regular daily use and should not be used for the relief of symptoms in an acute attack.
Nedocromil is not recommended for use in children 6 years of age and younger.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.